New study tests if tumor genes and organoids can outsmart pancreatic cancer
NCT ID NCT06615830
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study will enroll 185 people with metastatic pancreatic cancer to see if analyzing tumor genes and lab-grown organoids can predict which standard chemotherapy regimens work best. Researchers will compare predicted drug sensitivity to actual patient outcomes. The tests are experimental and not used to guide treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Transcriptome-based OncoTreat/OncoTarget testing and patient-derived organoids
- What this could lead to
- If successful, this could show that combining genetic analysis with organoid testing helps predict effective treatments for pancreatic cancer, paving the way for more personalized therapy.
- What could go wrong
- This is an observational study, not a treatment trial. The tests are experimental and not yet proven to improve outcomes. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug immune attack shrink Hard-to-Treat pancreatic tumors?
- Can a new imaging trick spot pancreatic cancer without a biopsy?
- Can a smart drug home in on Hard-to-Treat cancers?
- Can three common drugs boost chemotherapy against pancreatic cancer?
- Can an immunotherapy cocktail slow pancreatic cancer? a new trial aims to find out.
- Can High-Dose vitamin c boost chemo against pancreatic cancer?